← Back to Search

High Power for Tobacco Use

N/A
Waitlist Available
Led By Tracy Smith, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 3
Awards & highlights

Study Summary

This trial is testing how much people like different types of e-cigarettes and if they help people smoke less. People will use e-cigarettes for 3 weeks and fill out daily and weekly surveys.

Eligible Conditions
  • Tobacco Use
  • Smoking

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean Cigarettes Per Day
Secondary outcome measures
Average Number of E-cigarette Puffing Episodes
Number of Choices to Smoke Cigarette in Lab Setting

Trial Design

4Treatment groups
Experimental Treatment
Group I: Low Concentration / Low PowerExperimental Treatment2 Interventions
Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a low power for three weeks.
Group II: Low Concentration / High PowerExperimental Treatment2 Interventions
Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a high power for three weeks.
Group III: High Concentration / Low PowerExperimental Treatment2 Interventions
Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a low power for three weeks.
Group IV: High Concentration / High PowerExperimental Treatment2 Interventions
Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a high power for three weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Power
2019
N/A
~100
High Power
2019
N/A
~100
Low Concentration
2019
N/A
~100
High Concentration
2019
N/A
~100

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,488 Previous Clinical Trials
2,622,559 Total Patients Enrolled
30 Trials studying Tobacco Use
6,141 Patients Enrolled for Tobacco Use
Medical University of South CarolinaLead Sponsor
940 Previous Clinical Trials
7,396,901 Total Patients Enrolled
9 Trials studying Tobacco Use
42,275 Patients Enrolled for Tobacco Use
Tracy Smith, PhDPrincipal Investigator - Medical University of South Carolina
Carolinas HealthCare Urgent Care - Steele Creek, Steele Creek Urgent Care
Medical University Of South Carolina College Of Medicine (Medical School)
1 Previous Clinical Trials
31 Total Patients Enrolled

Media Library

High Power Clinical Trial Eligibility Overview. Trial Name: NCT03844672 — N/A
Tobacco Use Clinical Trial 2023: High Power Highlights & Side Effects. Trial Name: NCT03844672 — N/A
High Power 2023 Treatment Timeline for Medical Study. Trial Name: NCT03844672 — N/A
Tobacco Use Research Study Groups: High Concentration / High Power, Low Concentration / Low Power, Low Concentration / High Power, High Concentration / Low Power
~15 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top